Introduction
Type 2 diabetes
TYPE 2 DIABETES, TYPE 2 DIABETES
Type 2 diabetes tends to occur in adults because of a continuous increase in the blood glucose level, which is caused by insufficient insulin secretion or difficulty in the use of insulin for various reasons. Among all of the type 2 diabetes patients, evidence suggests that women experience a higher excess mortality than men (In the early 1980s, glucagon-like peptide 1 (GLP-1) was found to be the glucagon-stimulating enzyme cleavage product (Liraglutide is a commonly used glucagon-like peptide 1 (GLP-1) receptor agonist. Unlike short-acting compounds, long-acting GLP-1 receptor agonists do not appear to substantially affect gastric motility when taken for a long time. Long-acting GLP-1 receptor agonists lack influence on gastric emptying rate76. Dulaglutide is a GLP-1 peptide fused with IgG. Compared with natural GLP-1, Dulaglutide shows extended biological activity due to its extended half-life (~90 hours), which supports the weekly administration of the drug (Dulaglutide is one GLP-1 Fc fusion protein that activates GLP-1 receptors and promotes glucose-dependent insulin secretion, which helps reduce fasting and postprandial glucose levels (The mechanism of action of Dulaglutide in decreasing blood glucose.